ICD-10 Coding for Apixaban Therapy(D68.9, I48.0U, I48.91)
Explore detailed ICD-10 coding guidelines for apixaban, including codes for atrial fibrillation and adverse effects.
Complete code families applicable to Apixaban Therapy
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| I48.91 | Unspecified atrial fibrillation | Use for patients with non-valvular atrial fibrillation on apixaban for stroke prevention. |
|
| T45.515A | Adverse effect of anticoagulants, initial encounter | Use when a patient experiences a bleeding complication directly linked to apixaban. |
|
| Z79.01 | Long term (current) use of anticoagulants | Use for patients on long-term apixaban therapy. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutApixaban Therapy
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Apixaban Therapy.
Failure to document CHA₂DS₂-VASc score
Impact
Clinical: Inadequate risk assessment for stroke., Regulatory: Non-compliance with treatment guidelines., Financial: Potential for denied claims.
Mitigation
Regularly update CHA₂DS₂-VASc score in patient records., Use templates to ensure complete documentation.
Using D68.9 for coagulopathy due to anticoagulants
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Inaccurate data on anticoagulant use.
Mitigation
Use Z79.01 for long-term use and T45.515A for adverse effects.
Anticoagulant Use Documentation
Impact
Inadequate documentation of long-term anticoagulant therapy.
Mitigation
Use standardized templates to ensure complete documentation.